THERAPY Colorectal cancer: how to teach an old drug new tricks

摘要

Subclassification of colorectal cancers can inform patient prognosis and response to treatment. Beyond these functions, a recent study demonstrates that molecular subtyping can also play an important part in rational drug discovery, uncovering new indications for drugs previously thought ineffective.